FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-125674.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-125674v1
fj.08-125674v2
23/6/1946    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by González-Périz, A.
Right arrow Articles by Clària, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by González-Périz, A.
Right arrow Articles by Clària, J.
(The FASEB Journal. 2009;23:1946-1957.)
© 2009 FASEB

Obesity-induced insulin resistance and hepatic steatosis are alleviated by {omega}-3 fatty acids: a role for resolvins and protectins

Ana González-Périz*, Raquel Horrillo*, Natàlia Ferré*, Karsten Gronert{ddagger}, Baiyan Dong{ddagger}, Eva Morán-Salvador*, Esther Titos*, Marcos Martínez-Clemente*, Marta López-Parra*, Vicente Arroyo{dagger} and Joan Clària*

* Department of Biochemistry and Molecular Genetics and

{dagger} Liver Unit, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi I Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, University of Barcelona, Barcelona, Spain; and

{ddagger} Center for Eye Disease and Development, School of Optometry, University of California, Berkeley, California, USA

1Correspondence: Department of Biochemistry and Molecular Genetics, Hospital Clínic, Villarroel 170, Barcelona 08036, Spain. E-mail: jclaria{at}clinic.ub.es

Omega-3-polyunsaturated fatty acids ({omega}-3-PUFAs) have well-documented protective effects that are attributed not only to eicosanoid inhibition but also to the formation of novel biologically active lipid mediators (i.e., resolvins and protectins). In this study, we examined their effects on ob/ob mice, an obesity model of insulin resistance and fatty liver disease. Dietary intake of {omega}-3-PUFAs had insulin-sensitizing actions in adipose tissue and liver and improved insulin tolerance in obese mice. Genes involved in insulin sensitivity (PPAR{gamma}), glucose transport (GLUT-2/GLUT-4), and insulin receptor signaling (IRS-1/IRS-2) were up-regulated by {omega}-3-PUFAs. Moreover, {omega}-3-PUFAs increased adiponectin, an anti-inflammatory and insulin-sensitizing adipokine, and induced AMPK phosphorylation, a fuel-sensing enzyme and a gatekeeper of the energy balance. Concomitantly, hepatic steatosis was alleviated by {omega}-3-PUFAs. A lipidomic analysis with liquid chromatography/mass spectrometry/mass spectrometry revealed that {omega}-3-PUFAs inhibited the formation of {omega}-6-PUFA-derived eicosanoids, while triggering the formation of {omega}-3-PUFA-derived resolvins and protectins. Moreover, representative members of these lipid mediators, namely resolvin E1 and protectin D1, mimicked the insulin-sensitizing and antisteatotic effects of {omega}-3-PUFAs and induced adiponectin expression to a similar extent that of rosiglitazone, a member of the thiazolidinedione family of antidiabetic drugs. Taken together, these findings uncover beneficial actions of {omega}-3-PUFAs and their bioactive lipid autacoids in preventing obesity-induced insulin resistance and hepatic steatosis.—González-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López-Parra, M., Arroyo, V., Clària, J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by {omega}-3 fatty acids: a role for resolvins and protectins.


Key Words: adiponectin • fatty liver disease • adipose tissue • lipid mediators




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
A. J. Leedom, A. B. Sullivan, B. Dong, D. Lau, and K. Gronert
Endogenous LXA4 Circuits Are Determinants of Pathological Angiogenesis in Response to Chronic Injury
Am. J. Pathol., January 1, 2010; 176(1): 74 - 84.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Li, Y. Sun, C.-P. Liang, E. B. Thorp, S. Han, A. W. Jehle, V. Saraswathi, B. Pridgen, J. E. Kanter, R. Li, et al.
Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet
Circ. Res., November 20, 2009; 105(11): 1072 - 1082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.